Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
LAQV@REQUIMTE, Department of Chemistry & Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre, 4169-007, Porto, Portugal.
Sci Rep. 2017 Nov 14;7(1):15534. doi: 10.1038/s41598-017-15452-z.
Efflux pumps of the ATP-binding cassette transporters superfamily (ABC transporters) are frequently involved in the multidrug-resistance (MDR) phenomenon in cancer cells. Herein, we describe a new atomistic model for the MDR-related ABCG2 efflux pump, also named breast cancer resistance protein (BCRP), based on the recently published crystallographic structure of the ABCG5/G8 heterodimer sterol transporter, a member of the ABCG family involved in cholesterol homeostasis. By means of molecular dynamics simulations and molecular docking, a far-reaching characterization of the ABCG2 homodimer was obtained. The role of important residues and motifs in the structural stability of the transporter was comprehensively studied and was found to be in good agreement with the available experimental data published in literature. Moreover, structural motifs potentially involved in signal transmission were identified, along with two symmetrical drug-binding sites that are herein described for the first time, in a rational attempt to better understand how drug binding and recognition occurs in ABCG2 homodimeric transporters.
ATP 结合盒转运蛋白超家族(ABC 转运蛋白)的外排泵通常与癌细胞中的多药耐药(MDR)现象有关。在此,我们基于最近发表的 ABCG5/G8 固醇转运体的晶体结构,描述了一种新的与 MDR 相关的 ABCG2 外排泵(也称为乳腺癌耐药蛋白(BCRP))的原子模型,该结构属于 ABCG 家族,参与胆固醇稳态。通过分子动力学模拟和分子对接,对 ABCG2 同源二聚体进行了深入的特征描述。全面研究了转运体结构稳定性中重要残基和模体的作用,结果与文献中已发表的可用实验数据非常吻合。此外,还确定了可能参与信号传递的结构模体,以及两个对称的药物结合位点,这是首次在 ABCG2 同源二聚体转运体中描述的,旨在更好地理解药物结合和识别如何在 ABCG2 同源二聚体转运体中发生。